Highlights
-
There are 27 EVT-capable stroke centres and 178 thrombolysis-only centres in Canada.
-
There is variation across the provinces in the availability of stroke coordinators and neurologists in the emergency department.
-
The majority of provinces have limited or no availability of stroke specialist physicians on-site in the emergency department.
Introduction
Disability and death due to ischaemic stroke can be mitigated with timely acute reperfusion treatments using intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT). IVT with alteplase 1,Reference Wardlaw, Murray, Berge and del Zoppo2 and now tenecteplase (TNK) Reference Menon, Buck and Singh3,Reference Warach, Dula and Milling4 provides a first line of treatment for acute ischaemic stroke patients and is widely available across Canada at hospitals that are equipped with a CT scanner and have access to expertise to medically treat patients with thrombolysis. EVT is a relatively new and highly efficacious treatment Reference Goyal, Demchuk and Menon5,Reference Goyal, Menon and van Zwam6 that requires highly specialized angiography infrastructure, devices and personnel, restricting its availability to specialized sites at larger urban and mostly tertiary care hospitals.
Both treatments are highly time dependent, Reference Emberson, Lees and Lyden7,Reference Saver, Goyal and van der Lugt8 so it is critical that stroke systems are created to ensure that all citizens can have timely access to hyperacute ischaemic stroke treatment. Health systems across Canada have realized the need for structured acute stroke systems of care that ensure suspected stroke patients are directed by ambulance services to designated stroke centres to ensure timely access to treatment. Lack of well-designed systems of care is a critical factor associated with worse stroke outcomes. Reference Adeoye, Nyström and Yavagal9 Hence, appropriate stroke centre designation and selective triage of suspected acute stroke patients for bypass of non-designated hospitals can significantly improve the utilization of treatment and efficient time to treatment from onset, resulting in improved outcomes. Stroke centre designations are based on several criteria including the availability of neuroimaging, a dedicated stroke unit with treatment protocols, staffing with qualified personnel and the range of treatment capabilities. Reference Waldman, Tadi, Khan Suheb and Rawal10 There are heterogeneities in the conventions of designating stroke centres globally. For example, in the USA, stroke centre designations are mostly based on the recommendations of the Brain Attack Coalition, a non-profit professional group dedicated to reducing the burden of stroke. 11 Four levels of stroke centres are recognized: comprehensive stroke centre (CSC), thrombectomy-capable stroke centre, primary stroke centre (PSC) and acute stroke-ready hospital (thrombolysis-ready hospitals). Reference Adeoye, Nyström and Yavagal9,Reference Bulwa and Chen12 CSCs provide the highest level of stroke care including EVT treatment at all times and have neuro-intensive care and neurosurgery on-site; thrombectomy-ready centres have EVT treatment but not at all times or lack neuro-intensive care and neurosurgery on-site. PSCs do not have EVT on-site but provide thrombolysis at all times with an on-site stroke unit defined as a specialized, geographically defined hospital unit dedicated to the management of patients with stroke, while thrombolysis-ready centres provide thrombolysis at all times (this can be with or without telestroke capacity), but these centres do not have an on-site stroke unit. Reference Adeoye, Nyström and Yavagal9,Reference Bulwa and Chen12 Table 1 shows all four levels of stroke centre designation.
Table 1. Stroke centre designations
EVT = endovascular thrombectomy.
The purpose of this paper is to present the findings of a recent national stroke centre survey conducted in Canada. The primary objective of the survey was to scan the acute ischaemic stroke treatment landscape in Canada and gather preliminary information about each designated stroke centre, the level of stroke treatment provided and specialty of most responsible physician for acute reperfusion treatment decision-making, the use of telestroke, the availability of stroke clinical research professionals and the participation in clinical trials at each centre. The results from this study can help to identify opportunities for further optimization of stroke systems of care across all 10 provinces and 3 territories across Canada. This national stroke survey is part of an ongoing national stroke initiative called OPTIMISING ACCESS 13 that aims to ensure the highest level of quality in the treatment of acute ischaemic stroke patients with both thrombolysis and EVT across Canada, with the objective to reduce disparity between rural/remote and urban hospitals.
Methods
Survey design and distribution
The stroke centre survey was designed by the investigators (NK, AD, GS) with the purpose to obtain an overview of access to thrombolysis and EVT treatment for acute ischaemic stroke across Canada. The survey aimed to obtain information on each stroke hospital’s designation level (Table 1), who makes the treatment decision, if they have a local/regional stroke coordinator, and their transition to TNK (Table 2). The survey included a combination of several question types including multiple choice and open-text questions.
Table 2. National stroke survey questions
The survey was designed and administered electronically using the online webform from Microsoft Office Forms (Microsoft Corp, Redmond, WA) and was distributed to a convenience sample consisting of the members of the OPTIMISING ACCESS national roundtable. 13 The OPTIMISING ACCESS national roundtable was assembled at the inception of the project and consists of stroke neurologist(s) and provincial-level stroke administrator(s) dyads from every province and territory in Canada. The members of the national roundtable then circulated the survey to their network of hospitals in their province, ensuring that each province was reached. The survey was distributed in January 2024 and remained open until the final response was received from all 205 stroke centres.
Survey response audit and quality checks
The survey responses were collated and audited by two members of the research team (BA, NK). Survey responses were checked for completeness and accuracy. The audit process was performed in two stages. In the first stage, questionable responses (from a logical standpoint) were verified as each survey response was received. This included things like duplicate entries, defining the correct province for hospitals with close boundaries, etc. For this stage, the contact person on the national roundtable for the province or the person who filled the survey was contacted for verification. Prior to survey distribution, a master list of all possible stroke-treating hospitals in Canada was created in collaboration with the members of the national roundtable, which was used to track survey completion rates. For the final stage of the audit, after the responses was closed, the survey responses for each province were collated and sent to each provincial stroke coordinator and/or physician lead on the national roundtable to verify that each stroke-treating hospital in their province was accounted for and that the responses provided were accurate to the best of their knowledge. In this way, we were able to verify the accuracy and completeness of the designated stroke centres, which were included in this study.
Data analysis
The survey was exploratory in nature, and the survey variables were mostly categorical. Hence, analyses involved descriptive statistics (counts, percentages, mode) and graphical distributions performed as appropriate. Comparisons were made between provinces across Canada where possible. To calculate the crude and age-adjusted rate of stroke centres per 100,000 persons in each province, the most recent population data from the 2021 Canada census of population of each province were obtained from Statistics Canada. 14 The age-adjusted rates were calculated based on the population of adults aged 18 years and older, as paediatric stroke (stroke in infants and children < 18years) is rare and is often managed with different protocols. Reference Felling, Sun, Maxwell, Goldenberg and Bernard15 All analyses were conducted using Microsoft Excel Version 2406.
Results
The first survey response was received on 30 January 2024, while the last response was received on 9 August 2024.
Distribution of designated stroke centres in Canada
There are a total of 205 stroke centres in Canada, and they were all represented in the final completed survey. In addition to these 205 stroke centres, there are 25 thrombolysis-ready, ambulance bypass centres in Canada, which are capable of providing thrombolysis to walk-in or in-hospital stroke patients only. These sites were not included in any of the further analyses as they are not considered stroke centres. The provinces of Quebec (QC), Ontario (ON) and British Columbia had the largest numbers of stroke centres, respectively, and comprised over 65% of all stroke centres in Canada. Table 3 lists the count of all the stroke treatment centres in Canada.
Table 3. Count of stroke treatment centres in Canada
NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon; CSC = comprehensive stroke centre; PSC = primary stroke centre.
There are 27 EVT-capable stroke centres in Canada: 26 CSCs and 1 thrombectomy-ready centre. Ten (42%) of the CSCs in Canada are in the province of ON, which also has the only thrombectomy-ready centre in the country. There are no CSCs in the province of Prince Edward Island (PE) and in any of the three Canadian territories of Yukon (YT), Nunavut (NU) and Northwest Territory (NT). Stroke patients needing EVT in each of these provinces and territories are transferred inter-provincially; PE patients are transferred to the CSC located in NS, while the territories of YT and NT consult with and transfer eligible stroke patients to the CSCs located in Vancouver and Edmonton, respectively. The thrombolysis-ready stroke centre in Iqaluit, Nunavut, only serves a portion of the Nunavut population and consults with and transfers patients to Ottawa for EVT. The rest of Nunavut is split into regional health hubs that receive primary and advanced stroke care from Churchill, MB; Winnipeg, MB; Yellowknife, NT; and Edmonton, AB. The bulk of the stroke centres in Canada are thrombolysis-capable centres, comprising PSCs (n = 70, 34.1%) and thrombolysis-ready centres (n = 108, 52.7%) as shown in Table 3.
The distribution of thrombolysis and EVT-capable centres in Canada per 100,000 of the population in each of the provinces and territories is displayed in Table 4. The crude rate of thrombolysis-only centres per 100,000 of the population ranged from 0.22 in ON to 2.54 in the Territories, while EVT-capable centres ranged from 0.05 in Alberta to 0.20 in Newfoundland and Labrador. Age adjustment (to reflect the adult population 18 years and above) at most risk for stroke and eligible for treatment) increased the rate of thrombolysis and EVT-capable stroke centres per 100,000.
Table 4. Rate of thrombolysis-only and EVT-capable centres per 100,000
NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon; EVT = endovascular thrombectomy. EVT-capable sites include comprehensive stroke centres and thrombectomy-ready centres. Thrombolysis-only sites include primary stroke centres and thrombolysis-ready centres. +The age-adjusted rates were based on the population of adults aged 18 years and over from the 2021 Canada census of population.
The percentage composition of stroke centres in each of the provinces and territories in Canada is displayed in Figure 1, and the distribution of stroke centres on a map is shown in Figure 2. Alberta has the largest percentage composition of PSCs (75%) and the fewest proportion (12.5%) of thrombolysis-ready hospitals. Apart from the territories that were just composed of thrombolysis-ready centres, 80% of the thrombolysis-capable hospitals in Saskatchewan are thrombolysis-ready, and 75% of the thrombolysis-capable hospitals in Manitoba are thrombolysis-ready.
Figure 1. Percentage composition of stroke centres in Canada by province. Stroke centre types are expressed as a percentage of the total number of stroke centres in each province. NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon; CSC = comprehensive stroke centre; PSC = primary stroke centre.
Figure 2. Distribution of all 205 stroke centres across Canada. CSC = comprehensive stroke centre; PSC = primary stroke centre.
Availability of local or regional stroke coordinator funded by the health system
In Canada, 67% of the stroke centres have a local or regional stroke coordinator that was funded by the health system, although there is considerable variation among provinces (Figure 3). For instance, the provinces of Prince Edward Island, Nova Scotia and Alberta have provincially funded stroke coordinators for all their stroke centres. In contrast, there is no stroke coordinator available in Manitoba, Horizon Health Network (NB) or the Territories.
Figure 3. Availability of local or regional stroke coordinator funded by the health system. Bars show the percentage of stroke centres with provincially funded stroke coordinators in each province. NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon.
Availability of neurologists in the ED
Only 70 (34%) stroke centres in Canada have neurologists physically present in the ED to attend to stroke patients, with some of the sites (8.3%) having the available neurologists on a part-time or on-call basis only (Figure 4). When comparing by type of stroke centres, most of the EVT-capable centres (96.3%) had availability of a neurologist in the ED all or most of the time as expected, whereas neurologists were available in the ED in only 53.6% of PSCs and 5.5% of thrombolysis-ready centres. QC and ON had the greatest availability of neurologists in the ED (40%–42% of their stroke centres). There was no neurologist present in any of the stroke centres in the Territories.
Figure 4. Availability of neurologists on-site in the ED of stroke centres. Bars show the percentage availability of neurologists on-site in the ED in the stroke centres in each province. NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon.
The neurology expertise in the ED was further stratified by the availability of specialists who have received stroke-specific training via fellowship or the Canadian Stroke Consortium certification. Only nine provinces had stroke neurologists, and only five provinces had stroke neurologists available at all times. Stroke neurologists were available in the ED most or all the time in 8.3% of all the sites and were available sometimes in 14.6% of stroke centres in Canada. The remaining 77.1% of stroke centres in Canada did not have stroke-trained neurologists available in the ED (Figure 5). When stratified by the type of stroke centres, stroke neurologists were centred in the EVT-capable centres. Apart from one hospital, all (96.3%) of the EVT- capable centres had stroke neurologists on-site in the ED on a regular or sporadic basis. In contrast, stroke neurologists were available in the ED in only 29% of PSCs and 1% of the thrombolysis-ready centres.
Figure 5. Availability of stroke specialists on-site in the ED of stroke centres. Bars show the percentage availability of stroke-trained neurologists on-site in the ED in the stroke centres in each province. NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon.
Who makes the thrombolysis decision in the ED
There was involvement of neurology in the thrombolysis decision-making in most of the stroke centres, either physically in the ED or more commonly through telestroke consultation. For the purpose of this survey, telestroke was defined as consultation with a regional or provincial neurologist by telephone only or may include telehealth equipment. 156 (76%) stroke centres used neurology input alone for the thrombolysis decision-making. Another 17% of stroke centres used neurology input in combination with the expertise of other specialties such as general ED physicians and internists (Local Neurologist OR Telestroke +). Notably, there were 14 stroke centres (6.8%) that completely relied on non-neurologists for the thrombolysis decision-making in the ED. The thrombolysis decisions at these sites were made solely by the local emergency physician and/or general internist and were spread across the provinces of QC (6), NL (4), NS (2) and ON (2). The thrombolysis decision-making across stroke centres in Canada is displayed in Figure 6.
Figure 6. Physician specialty that makes the thrombolysis decision in the ED of stroke centres. Bars show the percentage of stroke centres across Canada that use each physician specialty in the thrombolysis decision-making.
Transition to intravenous TNK
As of the time of survey completion in August 2024, 73% of stroke centres in Canada had completely transitioned to the use of IV (intravenous) TNK, with variability across provinces. There was 100% uptake of IV TNK in all stroke centres in the provinces of PE, NS, SK and AB. A small number of stroke centres (4.4%) thrombolysed patients with either TNK or Alteplase, depending on who was working, with this model centred mostly in NL. About 20% of sites were working on the transition. Notably, no stroke centre in Manitoba or in the Northwest and Yukon territories had transitioned to TNK at the time of the survey. The transition to IV TNK across stroke centres in each province in Canada is displayed in Figure 7.
Figure 7. Stroke centre transition to intravenous TNK. NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon.
Participation in stroke clinical trials
Site participation rate in stroke clinical trials was minimal, with only 34 out of the 205 stroke centres in Canada (16.6%) indicating that they enrol patients in stroke clinical trials (Figure 8). The clinical trial participation was heavily restricted to the EVT-capable centres, with an 85% participation rate across the CSCs and thrombectomy-ready stroke centres. In contrast, stroke clinical trials participation was only 6.2% in the thrombolysis-capable centres. ON, QC and Alberta had the highest number of site participation in clinical trials, accounting for 76% of all clinical trials participation, while New Brunswick and the Territories had no participation.
Figure 8. Enrolment of patients in stroke clinical trials at stroke centres. The bars show the percentage of stroke centres in each province that enrol patients in clinical trials. NL = Newfoundland and Labrador; PE = Prince Edward Island; NB = New Brunswick; NS = Nova Scotia; QC = Quebec; ON = Ontario; MB = Manitoba; SK = Saskatchewan; AB = Alberta; BC = British Columbia; Territories include Nunavut, Northwest Territory and Yukon.
Discussion
This national stroke centre survey provides the first of its kind insight into the acute ischaemic stroke treatment landscape in Canada. Overall, there is provincial variability in the number of EVT-capable and thrombolysis-only stroke centres. For example, the provinces of Saskatchewan, Manitoba and Newfoundland and Labrador have a large proportion of thrombolysis-ready centres (80.0%, 75% and 72.7%, respectively), which shows a lack of availability of acute stroke units in these provinces. Alberta’s stroke centres are mostly PSCs or CSCs with the lowest proportion of thrombolysis-ready centres. ON has one centre in Thunder Bay that is a thrombectomy-ready centre, providing EVT services at certain times, which means that access to EVT for its catchment varies and patients may be diverted to a different hospital, delaying the start of EVT.
Another area of variability is in the availability of neurology expertise in the ED for treatment decision-making at the stroke centres. Neurology expertise is mostly concentrated in the EVT-capable stroke centres, whereas only 24% of thrombolysis-capable centres in Canada have neurologists physically present in the ED to attend to stroke patients, and that number drops to 11.8% when considering stroke neurologists. Since a large proportion of suspected stroke patients in Canada Reference Katsanos, Poppe and Swartz16 and globally Reference Rilianto, Kurniawan, Rajab and Prasetyo17,Reference Owolabi, Thrift and Martins18 are directed first to hospitals with thrombolysis-only capability, there is a need to build more support with stroke specialty at these centres. The use of telemedicine in stroke care has assisted with neurology access in thrombolysis-capable centres and has been shown to increase the implementation of evidence-based therapy in areas where neurologists are not readily accessible. Reference Hess and Audebert19–Reference Nguyen-Huynh, Klingman and Avins22 There was good telestroke coverage in the thrombolysis-capable centres in Canada, although 17% of stroke centres used neurology input in combination with the expertise of other specialties such as general ED physicians and internists to make treatment decisions for thrombolysis, while another 6.8% of stroke centres completely relied on non-neurology specialties for the thrombolysis decision-making in the ED. While this survey did not collect information on the kind of acute stroke training that the non-neurology specialists have received, it provides some foundation for further engagement to ascertain the level of on-site support and stroke-specific training that would be required to enhance their delivery of acute stroke care.
Stroke coordinators are an important part of the stroke team, providing integral support that has been shown to improve the acute stroke treatment process and across the entire spectrum of stroke care. Reference Purvis, Kilkenny, Middleton and Cadilhac23,Reference Cadilhac, Purvis and Kilkenny24 We have defined stroke coordinators as health system-funded positions that can also act as navigators. The role is typically filled by experienced stroke nurses or allied health professionals, who perform duties ranging from data collection and performance evaluation, coordination of patient flow and discharge and patient and staff education. Reference Purvis, Middleton and Alexandrov25,Reference Rattray, Damush, Luckhurst, Bauer-Martinez, Homoya and Miech26 Our survey revealed that in Canada, about 67% of the stroke centres had a local or regional stroke coordinator that was funded by the health system, although there was considerable variation among provinces, with Manitoba, the Horizon Health Network (NB) and the Territories lacking stroke coordinators in totality. Given the important role they play in ensuring quality of stroke care at their centres, there is need to identify the barriers preventing the provision of stroke coordinators and to identify sustainable models through which they can be funded. Reference Purvis, Middleton and Alexandrov27
As at the time of survey completion, there was good uptake (67%) of TNK across stroke centres in Canada, with variability across provinces. While several trials, Reference Huang, Cheripelli and Lloyd28–Reference Yogendrakumar, Churilov and Guha30 including the Canadian-led AcT trial, Reference Menon, Buck and Singh3 proved that TNK was not inferior to alteplase, the ease of use of TNK as a single bolus dose and its lower cost compared to alteplase provide evidence supporting that TNK provides efficiency. Reference Bach and Lui31 The transition to TNK can also facilitate faster transfer times from thrombolysis-only centre to the EVT-capable centre, thus facilitating lower door-in-door-out times. Reference Warach, Dula and Milling32 Most centres that have not yet transitioned are in the planning stages of transition, showing fast uptake of the latest evidence in Canada.
One of the differences observed in the survey was in the participation of stroke centres in clinical trials. Compared to an 85% participation rate in EVT-capable stroke centres, clinical trials participation was only 6.2% in thrombolysis-capable centres. In addition, larger provinces such as ON, QC and Alberta made up the bulk of participation. This is largely because urban teaching hospitals have existing research infrastructure to participate in trials. Reference Mudaranthakam, Gajewski and Krebill33,Reference Sabesan, Burgher and Buettner34 In addition to infrastructural constraints, rural hospitals often face more barriers in conducting clinical trials including insufficient research staffing, lower economic power, patients’ attitude to research including the hesitancy to travel and miss work because of research, education and language barriers and lack of equal research opportunities and investments from sponsors. Reference Mudaranthakam, Gajewski and Krebill33,Reference Farris, Crist, Miller and Shannon35 As a result, current stroke clinical trials are only representative of urban populations, and there is a need to develop ways to include PSCs and thrombolysis-ready centres in stroke clinical trials so that the results are inclusive of this patient demographic. Additionally, the inclusion of these centres will allow us to answer research questions that are unique to this patient group.
There are several strengths of this survey. This is the first attempt, to the best of our knowledge, to obtain a scan of the acute stroke landscape within Canada, with representation from all provinces and territories. Insights from this survey can facilitate conversations concerning the acute stroke treatment landscape in Canada and encourage the sharing of best practices among provinces for a more national oversight of stroke care. A limitation of this study is its survey design; the accuracy of the stroke treatment information provided relied on the knowledge of the individual completing the survey. Nonetheless, the careful data audit and quality control performed for the survey responses increase the confidence in the data presented in these results. We were also careful in choosing the respondent for the province by making sure that they are involved in provincial stroke care and that they understand the treatment landscape for their province. In addition, we sought additional inputs and validation from stroke coordinators who are well versed with provincial stroke care.
This survey provides a preliminary scan of the acute stroke treatment process in Canada, and several opportunities for future work abound. Future research efforts will be directed to perform geographic modelling to identify specific areas with poor access including the size of the population that has poor access to thrombolysis and EVT. This is an important step to help further understand the Canadian stroke treatment landscape and distribution of services. There is also a large gap in the understanding of the treatment landscape of haemorrhagic stroke within Canada, which could be the target of future research efforts.
This stroke centre survey is a first step in a large long-term national project called OPTIMISING ACCESS, 13 which aims to ensure the highest level of quality in the treatment of acute ischaemic stroke patients with both thrombolysis and EVT across Canada, with the aim to reduce disparity between rural/remote and urban hospitals.
Conclusions
The acute ischaemic stroke landscape in Canada is established; however, there is variation between provinces, presenting unique opportunities for collaboration. There is a need for greater availability of stroke neurologists and stroke coordinators and for diversifying site participation in clinical trials.
Author contributions
BA, AMD and NK designed the study. BA conducted the data analysis. BA and NK wrote the initial draft. AMD, GJS, RC, ME, TH-N, HW, BS, SA, JS, AD, MB, SH, AP, M-CC, SS, AHK, R-JSS, RS, EG, NS, RW, RC, M-LH, BM, BB, SA, AK, HS, KB and SA assisted with data collection, provided data validation and provided editorial input into the manuscript. NK holds the funds to conduct the study.
Funding statement
Funding for this work is provided by an NSERC Alliance grant (Title: Designing and Deploying a National Registry to Reduce Disparity in Access to Stroke Treatment and Optimise Time to Treatment, PI: Noreen Kamal).
Competing interests
NK is co-founder and part owner of DESTINE Health Inc. and holds leadership roles on the OPTIMISING ACCESS National Roundtable, Heart and Stroke’s Stroke Quality Committee and Advocacy Committee. NK and AD have received grant funds from Medtronic, and the project manager for the study is funded through this grant. AD has received royalties or licences and is listed on a Patent from Circle CVI and consulting fees from Roche and honoraria from Boehringer Ingelhiem and Astra Zeneca, participated on data safety monitoring board or advisory board with Philips for the WE-TRUST trial and holds a leadership role on the Canadian Stroke Consortium as the Chair for the Board of Directors. SA holds a leadership role in the Heart and Stroke Foundation of New Brunswick. AK holds the New Investigator Award with Heart and Stroke Foundation of Canada and has received consulting fees with Diamedica Inc. and Bayer Inc. SH holds a leadership role on the Acute and Episodic Care Network: Provincial Stroke Advisory Committee for NS Health. AP has received contracts or grants from Canadian Institutes of Health Research, Heart and Stroke Canada and Brain Canada, payment or honoraria from Roche Canada, payment for expert testimony from Canadian medical Protective Agency, participation on data safety monitoring board or advisory board for the Act Trial’s Safety Committee and a leadership role in the Canadian Stroke Consortium’s National Stroke Fellowship programme. NS has received grants or contracts from Brain Canada and Research Manitoba. MH has received support from Acute Care Alberta. RW has received grants or contracts from the SHRF Mobilization Grant. BB has participated in the data safety monitoring board or advisory board for Modafinil and Exercise for Post Stroke Fatigue (MODEX). TH-N has received support from the HPEI Organized Stroke Care Program as Provincial Stroke Coordinator.
Open access
